Providence heart transplant program receives CMS certification

February 1, 2022 Providence inScope Content Team

Author: Dan Oseran, M.D., executive medical director, Providence Heart Institute

Providence Heart Institute is pleased to announce that it has received certification from the Centers for Medicare & Medicaid Services (CMS).

The certification comes following a rigorous five-day review of the program by Oregon Health Authority. The review looked at the outcomes of 15 heart transplants performed at Providence St. Vincent Medical Center during the past 11 months, as well as infrastructure and care throughout the hospital.

Speaking on behalf of our heart transplant team and the entire Providence Heart Failure Program, we couldn’t be more pleased with the decision. The auditors said our program is very strong, and they found no infractions. This is a reflection of our team’s commitment to deliver safe and reliable care for these vulnerable patients.

Certification qualifications

Heart transplant programs must perform 10 transplants before they can apply for CMS certification, which is critical for reimbursement as many patients are government insured.

Providence Heart Institute announced its intent to start a transplant program in March 2019 after about 400 heart failure patients who previously received care at OHSU transferred their care to Providence. Providence Heart Institute performed its first transplant in July 2020.

Providence Heart Institute

Known across the United States and internationally, Providence Heart Institute treats more than 300,000 patients each year, including more than 13,000 heart failure patient visits.

Providence Heart Institute consists of more than 100 highly skilled clinicians who provide world-class care that includes the latest advances in diagnosis, treatment and cardiac surgery. Through clinical research trials, patients also have access to many new therapies before they become widely available. Our wellness and prevention programs help prevent heart disease and empower patients to become their healthiest selves.

For more information:

To refer a patient to the Heart Failure Program: 503-216-1182
For provider resources including referral information, care resources and a link to download the Providence Heart Now app for access to our specialists: http://providenceoregon.org/cardiaccaretools

About the Author

The inScope content team focuses on bringing you the latest in clinical news from our team of world-class medical providers and physician leaders.
More Content by Providence inScope Content Team

Welcome to your journey for creating a healthier you

Providence heart transplant program receives CMS certification

Certification qualifications

Providence Heart Institute

For more information:

About the Author

Previous Article

Next Article

Providence heart transplant program receives CMS certification

Certification qualifications

Providence Heart Institute

For more information:

About the Author

Previous Article

Next Article

Most Recent Articles

The Gamma Knife Esprit stereotactic radiosurgery system moves beyond a fixed headframe to target the most challenging areas of the brain with exceptional accuracy.

Thousands upon thousands of cancer patients and family members at Providence have benefited from the life-changing work of Dr. Walter Urba. Learn about his remarkable career.

What is required to make clinical trials accessible to people in Hood River and other Columbia Gorge communities? Learn more about why it's important to expand access to studies and cancer care.

This prestigious award recognizes Dr. Fox’s extraordinary contributions to the field of immunotherapy and his lifelong dedication to advancing cancer research.

A joint study between Providence, Microsoft and the University of Washington detailing work to create a novel AI-powered pathology model that will lay the foundation to improve patient outcomes.

Years after the start of the pandemic, more than 200 patients continue to be cared for at Providence for ongoing symptoms that remain from contracting COVID-19. Learn how Providence continues helping.

A new investigator-initiated study for patients with metastatic melanoma and HNSCC aims to evaluate a galectin-3 inhibitor as a way to “remove the brakes” from the immune system.

The advent of MRI scanning of the brain and spinal cord was a giant leap forward in improving the ability to diagnose multiple sclerosis with greater sensitivity and reliability.

Growing the surgical oncology programs at Providence Cancer Institute is a testament to our commitment to providing research-focused, comprehensive services and improving outcomes for patients.

During winter months when the days are shorter and darker, both postpartum depression and baby blues may be more difficult.

A study led by Dr. Christopher Darus may offer hope to women with persistent endometrial cancer. Currently, the prognosis is poor for women with this form of cancer.

Providence researchers say comprehensive genomic profiling can be pivotal in identifying gene mutations in a patient and tailoring personalized treatment strategies.

Being able to assess the level of fibrosis and make appropriate referrals is important in the care of patients with Steatotic Liver Disease (formerly known as Fatty Liver).